| Working on Wellness (WOW) Intervention (NCT01494207) | University of Cape Town | 2009-11-01 |
| Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine (NCT01020006) | Pharmacyclics LLC. | 2009-11-01 |
| The Effect of Tranexamic Acid on Postoperative Blood Loss and Coagulation in Patients With Preoperative Anemia Undergoing Off-Pump Coronary Artery Bypass Graft; Double Blind Randomized Control Study (NCT01067638) | Yonsei University | 2009-11-01 |
| Effect of a Medical Food Supplement in Hospitalized Patients Recovering From Surgery (NCT01011608) | Abbott Nutrition | 2009-11-01 |
| Alberta Clinical Trial in Optimizing Hypertension (NCT00878566) | University of Alberta | 2009-11-01 |
| Family Cardiac Caregiver Investigation to Evaluate Outcomes (NCT00990548) | Columbia University | 2009-11-01 |
| Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects (NCT01010282) | Allergan | 2009-11-01 |
| Oxytocin and Emotion Recognition (NCT01216605) | University Hospital Freiburg | 2009-11-01 |
| A Study With RO4917523 in Patients With Fragile X Syndrome (NCT01015430) | Hoffmann-La Roche | 2009-11-01 |
| Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study) (NCT01031667) | Yonsei University | 2009-11-01 |
| Bronchoscopic Lung Volume Reduction Using Blood (NCT01528267) | Chelsea and Westminster NHS Foundation Trust | 2009-11-01 |
| Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome (NCT01168700) | Universidad de Santander | 2009-11-01 |
| Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328) (NCT01345786) | Organon and Co | 2009-11-01 |
| The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology (NCT01112670) | University of Colorado, Denver | 2009-11-01 |
| A Study on M2a Magnum Total Hip Arthroplasty (NCT01010763) | Zimmer Biomet | 2009-11-01 |
| Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients (NCT01021943) | Instituto Nacional de Cardiologia Ignacio Chavez | 2009-11-01 |
| A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia (NCT01066000) | Hoffmann-La Roche | 2009-10-31 |
| A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00951275) | Hoffmann-La Roche | 2009-10-31 |
| A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs. (NCT00996203) | Hoffmann-La Roche | 2009-10-31 |
| A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis (NCT01007435) | Hoffmann-La Roche | 2009-10-31 |
| Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis (NCT00988247) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-10-31 |
| Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom (NCT00996853) | GlaxoSmithKline | 2009-10-31 |
| Tanezumab In Osteoarthritis Of The Hip Or Knee (NCT00985621) | Pfizer | 2009-10-30 |
| An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease (NCT01009281) | Novartis Pharmaceuticals | 2009-10-30 |
| Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability (NCT00986258) | Grünenthal GmbH | 2009-10-30 |
| Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease (NCT00985517) | Sangamo Therapeutics | 2009-10-29 |
| Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer (NCT01038778) | National Cancer Institute (NCI) | 2009-10-29 |
| Open Label Extension In Cancer Patients (NCT00830180) | Pfizer | 2009-10-29 |
| AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer (NCT00976911) | Hoffmann-La Roche | 2009-10-29 |
| Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease (NCT00984659) | GlaxoSmithKline | 2009-10-29 |
| Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia (NCT00943306) | Aegerion Pharmaceuticals, Inc. | 2009-10-29 |
| BeneFIX Drug Use Results Survey [All-Case Surveillance] (NCT01154231) | Pfizer | 2009-10-29 |
| Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00989651) | National Cancer Institute (NCI) | 2009-10-28 |
| Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01004978) | National Cancer Institute (NCI) | 2009-10-28 |
| National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] (NCT01104935) | Comprehensive Support Project for Oncology Research | 2009-10-28 |
| Elective Induction of Nulliparous Labor (NCT01076062) | Madigan Army Medical Center | 2009-10-27 |
| Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome (NCT01494324) | Memorial Sloan Kettering Cancer Center | 2009-10-27 |
| A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC) (NCT01054456) | Eisai Inc. | 2009-10-27 |
| Voice and Swallowing Outcomes Following Revision Anterior Cervical Spine Surgery (NCT01017055) | University of Alabama at Birmingham | 2009-10-26 |
| A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease (NCT00988598) | Pfizer | 2009-10-26 |
| Evaluation of FUSION™ Vascular Graft for Above Knee Targets (NCT01601496) | Maquet Cardiovascular | 2009-10-26 |
| Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 (NCT00984126) | Novo Nordisk A/S | 2009-10-26 |
| A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers (NCT00999128) | Genentech, Inc. | 2009-10-26 |
| Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects (NCT00996125) | GlaxoSmithKline | 2009-10-24 |
| Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease (NCT00925301) | Amicus Therapeutics | 2009-10-23 |
| A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028) (NCT00943761) | Merck Sharp & Dohme LLC | 2009-10-23 |
| Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child (NCT01012180) | National Human Genome Research Institute (NHGRI) | 2009-10-23 |
| Vanguard Rocc Post Market Surveillance (NCT03664791) | Zimmer Biomet | 2009-10-23 |
| Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study (NCT01006109) | National Institute of Neurological Disorders and Stroke (NINDS) | 2009-10-22 |
| Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteer (NCT00978003) | National Institutes of Health Clinical Center (CC) | 2009-10-22 |
| Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas (NCT01030900) | National Cancer Institute (NCI) | 2009-10-22 |
| Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (NCT01004003) | Boehringer Ingelheim | 2009-10-22 |
| Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient. (NCT06168877) | IRCCS San Raffaele | 2009-10-21 |
| A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005) (NCT00988884) | Merck Sharp & Dohme LLC | 2009-10-21 |
| Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours (NCT00979134) | AstraZeneca | 2009-10-21 |
| Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults. (NCT00945282) | ViiV Healthcare | 2009-10-20 |
| Paxil CR Bioequivalence Study Brazil - Fed Administration (NCT01339247) | GlaxoSmithKline | 2009-10-20 |
| Clinical Utility of Olfactory Rehabilitation: Treatment for Pacients With Neurosensorial Anosmia (NCT04957563) | Cristina Gomez Calero | 2009-10-20 |
| Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age (NCT00976820) | GlaxoSmithKline | 2009-10-20 |
| Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma (NCT01005745) | H. Lee Moffitt Cancer Center and Research Institute | 2009-10-20 |
| The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders (NCT00904709) | K. Sue Robinson | 2009-10-19 |
| Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT00963105) | Celgene | 2009-10-19 |
| Myelin, Glia and Depression in Type 2 Diabetes (NCT01327404) | University of Illinois at Chicago | 2009-10-19 |
| Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01054885) | GlaxoSmithKline | 2009-10-19 |
| Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study (NCT01018186) | GlaxoSmithKline | 2009-10-19 |
| A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes (NCT00976261) | GlaxoSmithKline | 2009-10-17 |
| Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development (NCT01020669) | National Institute on Drug Abuse (NIDA) | 2009-10-16 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| Evaluation of Outcome Measures for Patients Diagnosed With Traumatic Brain Injury (NCT01020318) | National Institutes of Health Clinical Center (CC) | 2009-10-16 |
| SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS (NCT00996840) | GlaxoSmithKline | 2009-10-16 |
| A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036) (NCT00989079) | Merck Sharp & Dohme LLC | 2009-10-16 |
| Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation (NCT00930579) | Columbia University | 2009-10-16 |
| A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer (NCT00950300) | Hoffmann-La Roche | 2009-10-16 |
| BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC) (NCT00979576) | Boehringer Ingelheim | 2009-10-16 |
| An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors (NCT01040312) | Daiichi Sankyo Co., Ltd. | 2009-10-15 |
| Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1) (NCT01024673) | University of Pittsburgh | 2009-10-15 |
| An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC) (NCT01039506) | Daiichi Sankyo Co., Ltd. | 2009-10-15 |
| First Time in Human Study With GSK1325756 (NCT01209052) | GlaxoSmithKline | 2009-10-15 |
| An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836. (NCT00996268) | GlaxoSmithKline | 2009-10-15 |
| Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People (NCT00992784) | GlaxoSmithKline | 2009-10-15 |
| Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer (NCT00984282) | Bayer | 2009-10-15 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes (NCT00992511) | GlaxoSmithKline | 2009-10-14 |
| Shanghai Parkinson's Study (NCT00999388) | National Institute of Environmental Health Sciences (NIEHS) | 2009-10-14 |
| Study of Ataluren (PTC124) in Hemophilia A and B (NCT00947193) | PTC Therapeutics | 2009-10-14 |
| Biomarker Discovery and Validation in Lung Cancer (NCT01147562) | Dr. Guy Berchem | 2009-10-14 |
| Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children (NCT00980005) | GlaxoSmithKline | 2009-10-13 |
| Study of Gene Modified Immune Cells in Patients With Advanced Melanoma (NCT00910650) | Jonsson Comprehensive Cancer Center | 2009-10-13 |
| Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1) (NCT00979407) | GlaxoSmithKline | 2009-10-12 |
| Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma (NCT00932698) | Millennium Pharmaceuticals, Inc. | 2009-10-12 |
| Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination (NCT00984139) | GlaxoSmithKline | 2009-10-12 |
| Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days (NCT00989404) | GlaxoSmithKline | 2009-10-12 |
| A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris (NCT01019603) | Stiefel, a GSK Company | 2009-10-12 |
| Efficacy and Safety Study of Elagolix in Women With Endometriosis (NCT00973973) | AbbVie | 2009-10-12 |
| Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older (NCT00985088) | GlaxoSmithKline | 2009-10-11 |
| Hematopoietic Stem Cell Transplant in Devic's Disease (NCT00787722) | Northwestern University | 2009-10-10 |
| Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study (NCT01007266) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-10-09 |
| The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. (NCT03747068) | HaEmek Medical Center, Israel | 2009-10-09 |
| A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation (NCT00910962) | GlaxoSmithKline | 2009-10-08 |
| VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years (NCT00995982) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-08 |
| Preventing Diabetic Osteoporosis With Exercise (NCT03930758) | University of Michigan | 2009-10-08 |